Sharon Benzeno
Chief Commercial Ofc Imm Med · Adaptive Biotechnologies Corp
- 2025
- Jun 30, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sharon Benzeno files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chad M. Robins - $37.85M in ADPT purchases and sales in the last 12 months
- Harlan S. Robins - $29.48M in ADPT purchases and sales in the last 12 months
- Julie Rubinstein - $16.25M in ADPT purchases and sales in the last 12 months
- Francis Lo - $11.99M in ADPT purchases and sales in the last 12 months
- Kyle Piskel - $3.58M in ADPT purchases and sales in the last 12 months
- Peter M. Neupert - $3.14M in ADPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sharon Benzeno?
Sharon Benzeno is a corporate insider, tracked as Chief Commercial Ofc Imm Med of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sharon Benzeno last file a Form 4?
The most recent primary Form 4 on record is dated 30 June 2026, one of 4 filings going back to 2025.
Has Sharon Benzeno been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($14.48M) across all tracked filings.
